• S.3386 - Protecting America From Foreign Investors Compromised by the Chinese Communist Party Act of 2020 Sen. Tom Cotton (R-AR)

    This bill requires the Committee on Foreign Investment in the United States to consider whether a foreign person that is a party to a transaction undergoing review by the Committee is connected to a foreign country that has installed information and communications technology designed, developed, manufactured, or supplied by persons owned or controlled by, or subject to the jurisdiction or direction of, a foreign adversary, and for other purposes.

  • H.R.6152 - Protecting America From Foreign Investors Compromised by the Chinese Communist Party Act of 2020 Rep. Mike Gallagher (R-WI-1)

    This bill requires the Committee on Foreign Investment in the United States to consider whether a foreign person that is a party to a transaction undergoing review by the Committee is connected to a foreign country that has installed information and communications technology designed, developed, manufactured, or supplied by persons owned or controlled by, or subject to the jurisdiction or direction of, a foreign adversary, and for other purposes.

  • S.3537 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020 Sen. Tom Cotton (R-AR)

    Legislation ends U.S. dependence on China for pharmaceutical manufacturing. The bill's key restrictions would go into effect in 2022.

  • H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020 Rep. Mike Gallagher (R-WI-8)

    Legislation ends U.S. dependence on China for pharmaceutical manufacturing. The bill's key restrictions would go into effect in 2022

  • S.3432 - Securing America's Medicine Cabinet Act of 2020 Sen. Marsha Blackburn (R-TN)

    This bill supports the advanced manufacturing technologies program of the Food and Drug Administration, to establish National Centers of Excellence in Advanced Pharmaceutical Manufacturing.

  • H.R.6708 - Securing America's Medicine Cabinet Act of 2020 Rep. Vern Buchanan (R-FL-18)

    This bill supports the advanced manufacturing technologies program of the Food and Drug Administration, to establish National Centers of Excellence in Advanced Pharmaceutical Manufacturing.

  • H.R.6690 - BEAT CHINA ACT Rep. Chip Roy (R-TX-2)

    This legislation will offer a few specific changes to the tax code, and will allow qualifying companies to obtain beneficial tax treatments for manufacturing in U.S. territories. This legislation will help end the United States’ pharmaceutical dependency on foreign countries, and ensure that our national security is not at risk through threats to the medical supply chain.

Pages